CIT can broadcast your seminar, conference or meeting live to a world-wide
audience over the Internet as a real-time streaming video. The event can
be recorded and made available for viewers to watch at their convenience
as an on-demand video or a downloadable file. CIT can also broadcast
NIH-only or HHS-only content.
The 2018 NIH AD Research Summit will bring together researchers and opinion leaders from academia, industry, federal agencies, private foundations and public advocacy groups working on Alzheimer's and other complex diseases with the goal to evaluate progress towards the AD research implementation milestones and to continue the development of an integrated, multidisciplinary, translational research agenda necessary to address critical knowledge gaps and enable precision medicine for AD. Key to achieving this goal is the identification of: 1) resources/infrastructure and multi-stakeholder partnerships necessary to successfully implement this research agenda and 2) strategies to engage patients, caregivers and citizens as direct partners in research.
This key strategic planning event is tied to the implementation of the first research goal of the National Plan to Address Alzheimer's (NAPA), to treat and prevent Alzheimer's disease by 2025. The 2018 Summit builds on the foundation laid by the NIH AD Research Summits held in 2012 and 2015 and the NIH ADRD Research Summits of 2013 and 2016.
The meeting program will be organized around 7 major themes/sessions:
Novel Mechanistic Insights into the Complex Biology and Heterogeneity of AD
Enabling Precision Medicine for AD
Translational Tools and Infrastructure to Enable Predictive Drug Development
Understanding the Impact of the Environment to Advance Disease Prevention
Advances in Disease Monitoring Assessment and Care
Building an Open Science Research Ecosystem to Accelerate AD Therapy Development
Each session will feature progress achieved towards key research implementation milestones and highlight emerging research trends, followed by a moderated panel discussion focused on outstanding questions/knowledge gaps/research needs.
The general program will be followed by a writing session during which a select group of experts together with NIA/NIH staff and NAPA Council members will evaluate progress to date and formulate recommendations which will be used as the basis for updating and refining the research implementation milestones for measuring progress towards the goal to prevent and treat AD by 2025.